| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/07/2013 | US20130035338 Eyelid treatment |
| 02/07/2013 | US20130035337 Fused bicyclic heteroaryl derivative |
| 02/07/2013 | US20130035336 Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor for treating cancer |
| 02/07/2013 | US20130035335 8-ethyl-6-(aryl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 02/07/2013 | US20130035334 Inhibitors of bruton's tyrosine kinase |
| 02/07/2013 | US20130035333 Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders |
| 02/07/2013 | US20130035332 Substituted 1,3-Benzothiazol-2(3H)-Ones and [1,3]Thiazolo[5,4-B]Pyridin-2(IH)-Ones as Positive Allosteric Modulators of MGLUR2 |
| 02/07/2013 | US20130035331 Thiazole and oxazole kinase inhibitors |
| 02/07/2013 | US20130035330 Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
| 02/07/2013 | US20130035329 Therapeutically active compositions and their methods of use |
| 02/07/2013 | US20130035328 Antiviral compounds and methods |
| 02/07/2013 | US20130035327 Modulators of ATP-Binding Cassette Transporters |
| 02/07/2013 | US20130035326 Biaryl compounds and methods of use thereof |
| 02/07/2013 | US20130035325 Kinase inhibitors |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/07/2013 | US20130035323 Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/07/2013 | US20130035322 Gold complexes |
| 02/07/2013 | US20130035321 Compounds for the treatment of ocular cancer |
| 02/07/2013 | US20130035320 Pyrrolidine derivatives |
| 02/07/2013 | US20130035319 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 02/07/2013 | US20130035318 C-17 and c-3 modified triterpenoids with hiv maturation inhibitory activity |
| 02/07/2013 | US20130035317 Di-Aspirin Derivatives |
| 02/07/2013 | US20130035316 Pharmaceutical composition comprising metformin and rosuvastatin |
| 02/07/2013 | US20130035315 Crystallization method and bioavailability |
| 02/07/2013 | US20130035314 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
| 02/07/2013 | US20130035313 Nucleoside Phosphonate Salts |
| 02/07/2013 | US20130035312 Cathepsin cysteine protease inhibiors |
| 02/07/2013 | US20130035311 Prochelators for inhibiting metal-promoted oxidative stress |
| 02/07/2013 | US20130035310 Piperidine and Piperazine Phenyl Sulfonamides as Modulators of Ion Channels |
| 02/07/2013 | US20130035309 Ophthalmic sealant composition and method for use |
| 02/07/2013 | US20130035307 Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers |
| 02/07/2013 | US20130035306 Process for preparing purine nucleosides |
| 02/07/2013 | US20130035305 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases |
| 02/07/2013 | US20130035304 Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders |
| 02/07/2013 | US20130035303 Compositions and methods for control of sand flies and other blood sucking insects |
| 02/07/2013 | US20130035302 Use of yessotoxin and analogues and derivatives thereof for treating and/or preventing neurodegenerative diseases linked to tau and beta amyloid |
| 02/07/2013 | US20130035301 Cdc7 kinase inhibitors and uses thereof |
| 02/07/2013 | US20130035300 Method of using pomegranate extracts for increasing prostate specific antigen doubling time |
| 02/07/2013 | US20130035299 Antimicrobial composition based on botanical extracts from oil palm vegetation liquor |
| 02/07/2013 | US20130035298 Pharmaceutical composition, methods for treating and uses thereof |
| 02/07/2013 | US20130035296 Therapeutic peptides |
| 02/07/2013 | US20130035288 Resorption Enhancers As Additives To Improve The Oral Formulation Of Non-Anticoagulant Sulfated Polysaccharides |
| 02/07/2013 | US20130035284 Small-molecule inhibitors of dengue and west nile virus proteases |
| 02/07/2013 | US20130035260 Genes involved in inflammatory bowel diseases and use thereof |
| 02/07/2013 | US20130034617 Gallium compositions for the treatment of liver cancer and methods of use |
| 02/07/2013 | US20130034616 Compounds useful as inhibitors of atr kinase |
| 02/07/2013 | US20130034612 Dermatological compositions comprising avermectin nanocapsules |
| 02/07/2013 | US20130034610 Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| 02/07/2013 | US20130034608 Long Circulating Nanoparticles for Sustained Release of Therapeutic Agents |
| 02/07/2013 | US20130034607 Tablet |
| 02/07/2013 | US20130034606 Immediate release tablet formulations |
| 02/07/2013 | US20130034605 Extended release pharmaceutical compositions containing paliperidone |
| 02/07/2013 | US20130034604 Extended release formulations of desvenlafaxine base |
| 02/07/2013 | US20130034603 Process for preparing pharmaceutical compositions of fingolimod |
| 02/07/2013 | US20130034601 Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| 02/07/2013 | US20130034599 Synthetic nanostructures including nucleic acids and/or other entities |
| 02/07/2013 | US20130034598 Inhibitors of akt/pkb with anti-tumor activity |
| 02/07/2013 | US20130034596 Use of synthetic polysulphated oligosaccharides as cleaning agents for a wound |
| 02/07/2013 | US20130034595 Local administration of gallium compositions to treat pain |
| 02/07/2013 | US20130034593 Method for Making Medical Devices Having Antimicrobial Coatings Thereon |
| 02/07/2013 | US20130034591 Novel compounds and compositions for targeting cancer stem cells |
| 02/07/2013 | US20130034578 Recombinant multimeric influenza proteins |
| 02/07/2013 | US20130034565 MOLECULES AND METHODS OF USING SAME FOR TREATING ErbB/ErbB LIGANDS ASSOCIATED DISEASES |
| 02/07/2013 | US20130034562 Selective androgen receptor modulators for treating diabetes |
| 02/07/2013 | US20130034555 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases |
| 02/07/2013 | US20130034549 Combination therapy for treating breast cancer |
| 02/07/2013 | US20130034543 Modulating xrn1 |
| 02/07/2013 | US20130034540 Immune Gene Signatures in Cancer |
| 02/07/2013 | US20130034539 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 02/07/2013 | US20130034537 Simultaneous co-treatment of physical and mental symptoms related to severe mental disorders by a specially fermented soy formulation (fsww08) |
| 02/07/2013 | US20130034536 Bile Acid Recycling Inhibitors for Treatment of Pancreatitis |
| 02/07/2013 | US20130034535 Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics |
| 02/07/2013 | US20130034522 Therapies for treating hepatitis c virus infection |
| 02/07/2013 | US20130034521 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 02/07/2013 | US20130034520 Hepatitis C Virus Inhibitors |
| 02/07/2013 | US20130034517 Targeted drug phosphorylcholine polymer conjugates |
| 02/07/2013 | US20130034516 Use of the modified polysaccharides for heparin neutralization |
| 02/07/2013 | US20130034510 Melanin modification compositions and methods of use |
| 02/07/2013 | US20130034504 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 02/07/2013 | US20130034503 Preventing or reducing drug abuse and overdose events |
| 02/07/2013 | US20130034501 Diarylhydantoin compounds |
| 02/07/2013 | US20130034500 Cationic Steroid Antimicrobial Compositions and Methods of Use |
| 02/07/2013 | US20130034497 Iodine-labeled homoglutamic acid and glutamic acid derivatives |
| 02/07/2013 | US20130034495 Isotopologues of 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol |
| 02/07/2013 | US20130034493 Methods and compositions for modulation of olfml3 mediated angiogenesis |
| 02/07/2013 | DE102011118024A1 New procaspase 1 expression inhibitor, useful for preventing and/or treating inflammatory diseases, which are autoinflammatory diseases |
| 02/07/2013 | DE102011080405A1 New substituted 3-biphenyl-3-yl-8,8-difluoro-4-hydroxy-1-azaspiro(4.5)dec-3-en-2-one derivatives useful for prophylaxis or therapy of tumor diseases comprising breast cancer, prostate cancer, colorectal cancer or non-small cell lung cancer |
| 02/07/2013 | CA2853849A1 Protein having activity to promote fatty acid chain elongation, gene encoding the same and use thereof |
| 02/07/2013 | CA2844197A1 Treatment of fibrosis using microrna-19b |
| 02/07/2013 | CA2844152A1 Stable anti-inflammatory solutions for injection |
| 02/07/2013 | CA2844058A1 Quinazoline compounds as serine/threonine kinase inhibitors |
| 02/07/2013 | CA2844054A1 Inhibitors of influenza viruses replication |
| 02/07/2013 | CA2844032A1 Method for treating cancer by combined use of drugs |
| 02/07/2013 | CA2844012A1 Micro-rnas and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions |
| 02/07/2013 | CA2843908A1 Oligosaccharides and oligosaccharide-protein conjugates derived from clostridium difficile polysaccaride ps-i, methods of synthesis and uses thereof, in particular as vaccines anddiagnostic tools |
| 02/07/2013 | CA2843885A1 Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates |
| 02/07/2013 | CA2843847A1 Use of (1r,5s)-(+)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane in the treatment of conditions affected by monoamine neurotransmitters |
| 02/07/2013 | CA2843836A1 Uracil derivative and use thereof for medical purposes |
| 02/07/2013 | CA2843809A1 Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one |
| 02/07/2013 | CA2843805A1 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |